Ornob Roy, MD
Urology · Charlotte, NCNPI 1891908430
Payments from drug & device makers
Across 81 payments — averaging $209.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$14K
- Boston Scientific$1K
- Urogen Pharma, Inc.$1K
- Johnson & Johnson$245
- Biom'up France SAS$209
- Olympus America Inc.$195
- plus $268 from 4 others
What the payments were for
- Consulting fees$1,5009%
- Speaking & faculty fees$11,21766%
- Travel & lodging$3032%
- Food & beverage$3,90823%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 23 | $13,525 |
| Boston Scientific | 23 | $1,452 |
| Urogen Pharma, Inc. | 20 | $1,052 |
| Johnson & Johnson | 6 | $245 |
| Biom'up France SAS | 2 | $209 |
| Olympus America Inc. | 2 | $195 |
| Neotract Inc. | 1 | $132 |
| Intuitive Surgical | 2 | $97 |
| Covidien LP | 1 | $31 |
| Histosonics, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (815) Thiola$12,568
- JELMYTO$496
- LithoVue$322
- HemoBlast Bellows$209
- GENERAL ERECTILE DYSFUNCTION$174
- GENERAL - THERAPIES$147
- UroLift$132
- Enseal X1$124
- Harmonic$124
- STRATAFIX$124
- ECHELON ENDOPATH$124
- VISTASEAL$124
- REZUM$120
- iTIND System$117
How this compares
$16,946 in reported general payments places this provider in the 85th percentile of 434 urology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 11 | $1,365 |
| Tamsulosin Hcl | 91 | $797 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 30 | $363 |
| Oxybutynin Chloride | 44 | $269 |
| Cefadroxil | 36 | $118 |
| Finasteride | 12 | $75 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $55 |
| Ciprofloxacin Hcl | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other urology in Charlotte
- Michael KennellyCharlotte$1.4M
- Peter ClarkCharlotte$332K
- Samuel PeretsmanCharlotte$282K
- Justin MatulayCharlotte$150K
- Manish PatelCharlotte$84K
- Kris GastonCharlotte$32K
- Jeremy HubbardCharlotte$28K
- Todd CohenCharlotte$18K
- Daniel GeorgeDurham$17.6M
- Robert LippittSmithfield$11.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.